Castle Biosciences Inc (CSTL): Koefisien rega marang pendapatan

The P/S time series on the GURU.Markets chart illustrates the valuation dynamics of Castle Biosciences (CSTL), where the 2.80 level captures the latest values. Growth is driven by the integration of genomic tests into oncology protocols, despite Medicare regulatory risks. Stability is ensured by the non-cyclical nature of diagnostics and insurance coverage, while human capital is sustained by a life-saving mission and the comfort provided in medical centers.

Castle Biosciences, Inc. (CSTL): Rasio rega marang pendapatan saka 04.07.2022 nganti 13.11.2026

Rincian analitis perusahaan Castle Biosciences Corp (CSTL)

- kuotasi saiki lan rata-rata prakiraan nilai:

Rega bursa castlebiosciences.com|CSTL - Bagan rega target

- data kapitalisasi bursa:

Kapitalisasi pasar Castle Biosciences Corp|CSTL - Nilai Perusahaan

- rincian nilai buku perusahaan:

Aset Bersih saben Saham Castle Biosciences|CSTL - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku castlebiosciences.com|CSTL - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Rasio Total Utang marang Ekuitas Castle Biosciences|CSTL - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Castle Bio|CSTL - Utang perusahaan|Utang-utang marang aset resik Castle Biosciences Corp|CSTL - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Castle Biosciences|Likuiditas cepet castlebiosciences.com

- data bathi resik lan rasio valuasi:

CSTL - Bathi resik|Bathi resik sing dikarepake Castle Biosciences|CSTL - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Castle Biosciences Inc|CSTL - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Castle Biosciences Corp|CSTL - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Castle Biosciences|CSTL - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan castlebiosciences.com|CSTL - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Castle Biosciences

- data total pendapatan lan volume dodolan:

CSTL - Pendapatan lan volume dodolan|Volume dodolan mangsa ngarep perusahaan castlebiosciences.com|CSTL - Multiplikator P/S|Rasio kapitalisasi marang dodolan sing dikarepake Castle Biosciences Corp

Analisis fundamental perusahaan:CSTL, castlebiosciences.com

The P/S multiple reflects the market value of the business relative to its revenue, allowing for an assessment of the premium paid for every dollar of sales. By analyzing the historical P/S values for Castle Biosciences (CSTL), an investor can determine whether expectations for expanded insurance coverage and new gastroenterology tests justify the current capitalization, which is critical for mitigating risks during a price correction.

Karo sapa Castle Biosciences saingan

CAI - Rega marang dodolan|Rasio rega marang pendapatan Guardant Health GH|Koefisien rega marang pendapatan Veracyte Inc (VCYT)|Celcuity Corp - Multiplikator P/S|Koefisien rega marang pendapatan GRAIL Bio GRAL|Myriad Genetics, Inc. (MYGN) - Rasio rega marang pendapatan|BNR - Koefisien rega marang pendapatan|VNRX (VolitionRx Ltd.) - Multiplikator P/S|Kapitalisasi marang pendapatan Biodesix Inc (BDSX)|Multiplikator P/S PRPO|Multiplikator P/S check-cap.com (CHEK)|Rasio rega marang pendapatan Mainz Biomed MYNZ|Koefisien rega marang pendapatan oncocyte.com (OCX)